WA-SORACOM
29.6.2022 11:02:08 CEST | Business Wire | Press release
Soracom , Inc., a global provider of advanced Internet of Things (IoT) connectivity, today announced that ThingsMatrix , an experienced IoT solutions provider that offers full turnkey services, has joined the Soracom Partner Space – a growing ecosystem for building and scaling IoT applications to advance asset monitoring for industrial enterprises.
ThingsMatrix offers a robust cloud-based platform designed to simplify IoT development and deployment processes for enterprises. The company’s turnkey solution includes three versatile components – device, platform and cellular connectivity – enabling a full range of functionality from simple tasks to complex actions. With custom, off-the-shelf, or bring your own devices available to track and monitor assets globally, ThingsMatrix offers the speed, security and scalability today’s industrial enterprises need to navigate the complexities of IoT, thus reducing risk and accelerating time-to-value.
“ThingsMatrix’s versatile turnkey device solutions and service platform paired with Soracom’s reliable and advanced IoT capabilities is a major step forward for total asset management,” said Tom Burton, ThingsMatrix’s president of global sales. “This collaboration means that industrial enterprises will now have the ability to solve complex issues with an all-in-one IoT solution that offers greater efficiency and seamless connectivity.”
Soracom announced the global expansion of the Soracom Partner Space in May 2022. The program now reaches more than 800 best-in-class members throughout the world, including more than 100 certified partners representing hardware, software, solutions, and integration services. Soracom Partner Space members help IoT innovators accelerate time to market with as-needed access to complementary, best-in-class solutions and services that are ready to integrate at every level of the IoT stack.
“Soracom is committed to democratizing the technologies that help IoT innovators accelerate speed to market and ensure success at scale,” said Nicolas Lesconnec, Soracom senior partnership manager. “In collaborating with ThingsMatrix, we are able to offer a proven portfolio of solutions to our customers and ecosystem partners looking to improve their asset monitoring capabilities.”
For more information, visit www.soracom.io/partners/thingsmatrix
About ThingsMatrix
ThingsMatrix is a world-class, global IoT solutions provider offering hardware, device management platform and connectivity. The company’s customizable and off-the-shelf solutions enable enterprises to simplify asset tracking, improve operations and reduce costs by remotely managing multiple devices and locations in a robust, unified dashboard. ThingsMatrix’s configurable and programmable architecture provides companies with a full range of functionality to securely collect, process, analyze and visualize IoT data in real time. Built on efficiency, versatility and affordability, the company’s turnkey solutions are designed to meet the needs of a wide range of vertical industries — from global leading operators to single contract customers. For more information, visit www.things-matrix.com .
About Soracom
Soracom is leading the democratization of IoT connectivity, offering robust solutions specifically designed to make it easy to build, operate, and scale IoT deployments. Founded in 2015, Soracom now serves more than 20,000 startups, SMBs and global enterprises across all industries, from agriculture, energy, construction and transportation to consumer electronics, manufacturing, real estate and healthcare. Customers trust Soracom for affordable, reliable connectivity that accelerates speed to market, makes it easy to connect to the cloud, and offers access to a worldwide partner ecosystem. More information is available at www.soracom.io .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220629005336/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom